Jiangsu Lanfeng Bio-chemical Co.,Ltd carries a market capitalization of 1.86B, placing it among publicly traded companies globally. Its enterprise value stands at 2.13B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.86B |
| Enterprise Value | 2.13B |
Jiangsu Lanfeng Bio-chemical Co.,Ltd currently has 375.28M shares outstanding.
| Shares Outstanding | 375.28M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
The price-to-sales ratio is 0.93, and the price-to-book ratio stands at -0.93.
| PE Ratio | N/A |
| PS Ratio | 0.93 |
| PB Ratio | -0.93 |
| P/TBV Ratio | 10.39 |
| P/FCF Ratio | 12.38 |
| P/OCF Ratio | N/A |
| EV / Sales | 0.99 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 10.02 |
Jiangsu Lanfeng Bio-chemical Co.,Ltd maintains a current ratio of 0.63, meaning it holds 0.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 257.30, indicating elevated leverage, while an interest coverage ratio of -2.60 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.63 |
| Quick Ratio | 0.26 |
| Debt / Equity | 257.30 |
| Debt / EBITDA | -3.96 |
| Interest Coverage | -2.60 |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -4.24 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 7.53 |
| Income Tax | -50.92M |
| Effective Tax Rate | N/A |
Jiangsu Lanfeng Bio-chemical Co.,Ltd's stock has declined approximately -6.76692% over the past 52 weeks. The 50-day moving average sits at 5.86, while the 200-day moving average is 7.09.
| Beta (5Y) | N/A |
| 52-Week Price Change | -6.76692% |
| 50-Day Moving Average | 5.86 |
| 200-Day Moving Average | 7.09 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Jiangsu Lanfeng Bio-chemical Co.,Ltd generated 2.14B in revenue and converted that into -157.91M in net income, yielding earnings per share of -0.64. EBITDA reached -164.96M, while operating income came in at -164.96M.
| Revenue | 2.14B |
| Gross Profit | 15.37M |
| Operating Income | -164.96M |
| Pretax Income | -290.78M |
| Net Income | -157.91M |
| EBITDA | -164.96M |
| EBIT | -164.96M |
| Earnings Per Share (EPS) | -0.64 |
Jiangsu Lanfeng Bio-chemical Co.,Ltd holds 768.57M in cash and equivalents against 653.58M in total debt, resulting in a net debt position of -197.11M. Total book value stands at -2.12B, with working capital of -1.12B providing operational flexibility.
| Cash & Cash Equivalents | 768.57M |
| Total Debt | 653.58M |
| Net Debt | -197.11M |
| Equity (Book Value) | -2.12B |
| Book Value Per Share | -5.65 |
| Working Capital | -1.12B |
After subtracting -160.16M in capital expenditures, free cash flow totaled -160.16M - equivalent to -0.43 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -160.16M |
| Free Cash Flow | -160.16M |
| FCF Per Share | -0.43 |
Jiangsu Lanfeng Bio-chemical Co.,Ltd operates with a gross margin of 0.72, reflecting its pricing power and cost economics. The operating margin of -7.71 and net profit margin of -7.38 provide insight into operational efficiency.
| Gross Margin | 0.72 |
| Operating Margin | -7.71 |
| Pretax Margin | -13.59 |
| Profit Margin | -7.38 |
| EBITDA Margin | -7.71 |
The company's payout ratio of -9.53 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.08 |
| Dividend Yield | N/A |
| Payout Ratio | -9.53 |
| Shareholder Yield | -9.38 |
| FCF Yield | 8.08 |
Jiangsu Lanfeng Bio-chemical Co.,Ltd's most recent stock split took place on April 27, 2012 with a 5:8 split ratio.
| Last Split Date | 4/27/2012 |
| Split Ratio | 5:8 |
Jiangsu Lanfeng Bio-chemical Co.,Ltd posts an Altman Z-Score of -0.51, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -0.51 |